Mice lacking the multidrug resistance protein 1 have a transiently impaired immune response during tuberculosis

Clinical and Experimental Immunology

Volumn 130, Issue 1, 2002, Pages 32-36

  Verbon, A ^a,b   Leemans, J C ^a   Weijer, S ^a   Florquin, S ^a   Van Der Poll, T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cytokines; Multidrug resistance protein 1; Tuberculosis

Indexed keywords

GAMMA INTERFERON; MULTIDRUG RESISTANCE PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; EXPERIMENTAL INFECTION; GRANULOMA; IMMUNE RESPONSE; KNOCKOUT MOUSE; LUNG; MOUSE; MOUSE STRAIN; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; STRAIN DIFFERENCE; SURVIVAL; TH1 CELL; TUBERCULOSIS; WILD TYPE;

ADMINISTRATION, INTRANASAL; ANIMALS; INTERFERON TYPE II; LIVER; LUNG; MICE; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; P-GLYCOPROTEIN; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS; TUBERCULOMA; TUBERCULOSIS, PULMONARY;

EID: 0036381121     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01952.x     Document Type: Article

References (15)

1. Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, Barnes PF. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 1995; 63:3231-4.
2. Surcel HM, Troye-Blomberg M, Paulie S et al. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 1994; 81:171-6.
3. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178:2249-54.
4. Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J Exp Med 1997; 186:39-45.
5. Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000; 92:1295-302.
6. Flens MJ, Zaman GJ, van der Valk P et al. Tissue distribution of the multidrug resistance protein. Am J Pathol 1996; 148:1237-47.
7. Lohoff M, Prechtl S, Sommer F et al. A multidrug-resistance protein (MRP)-like transmembrane pump is highly expressed by resting murine T helper (Th) 2, but not Th1 cells, and is induced to equal expression levels in Th1 and Th2 cells after antigenic stimulation in vivo. J Clin Invest 1998; 101:703-10.
8. Prechtl S, Roellinghoff M, Scheper R, Cole SP, Deeley RG, Lohoff M. The multidrug resistance protein 1: a functionally important activation marker for murine Th1 cells. J Immunol 2000; 164:754-61.
9. Wijnholds J, Evers R, van Leusden MR et al. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat Med 1997; 3:1275-9.
10. Juffermans NP, Florquin S, Camoglio L et al. Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J Infect Dis 2000; 182:902-8.
11. Leemans JC, Juffermans NP, Florquin S et al. Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J Immunol 2001; 166:4612-9.
12. Bean AG, Roach DR, Briscoe H et al. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 1999; 162:3504-11.
13. Orme IM, Roberts AD, Griffin JP, Abrams JS. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 1993; 151:518-25.
14. Smith SM, Dockrell HM. Role of CD8 T cells in mycobacterial infections. Immunol Cell Biol 2000; 78:325-33.
15. Abbaszadegan MR, Futscher BW, Klimecki WT, List A, Dalton WS. Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Res 1994; 54:4676-9.